Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB

Cancer Research

Volumn 60, Issue 7, 2000, Pages 1805-1809

  Ramsay, Robert G ^a   Friend, Annabel ^a   Vizantios, Yotta ^a   Freeman, Ruth ^a   Sicurella, Catherine ^a   Hammett, Fleur ^a   Armes, Jane ^a   Venter, Deon ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; CYCLOOXYGENASE 2; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT;

APOPTOSIS; ARTICLE; BINDING SITE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DRUG TARGETING; ELECTROPHORETIC MOBILITY; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTO-ONCOGENE PROTEINS C-MYB; RATS; TRANSCRIPTION, GENETIC;

EID: 0034032244     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Smalley, W. E., and DuBois, R. N. Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv. Pharmacol., 39: 1-20, 1997.
2. Taketo, M. M. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J. Natl. Cancer Inst., 90: 1609-1620, 1998.
3. Tsujii, M., Kawano, S., and DuBois, R. N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA, 94: 3336-3340, 1997.
4. Thompson, M. A., Rosenthal, M. A., Ellis, S. L., Friend, A. J., Zorbas, M. I., Whitehead, R. H., and Ramsay, R. G. c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression. Cancer Res., 58: 5168-5175, 1998.
5. Melani, C., Rivoltini, L., Parmiani, G., Calabretta, B., and Colombo, M. P. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. Cancer Res., 51: 2897-2901, 1991.
6. Ramsay, R. G., Thompson, M. A., Hayman, J. A., Reid, G., Gonda, T. J., and Whitehead, R. H. Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa. Cell Growth Differ., 3: 723-730, 1992.
7. Ramsay, R. G., Morrice, N., Van Eeden, P., Kanagasundaram, V., Nomura, T., De Blaquiere, J., Ishii, S., and Wettenhall, R. Regulation of c-Myb through protein phosphorylation and leucine zipper interactions. Oncogene. 11: 2113-2120, 1995.
8. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning. A Laboratory Manual, Ed., pp. 16.56-16.69. 2. New York: Cold Spring Harbor Laboratory, 1989.
9. Nakagoshi, H., Nagase, T., Kanei-Ishii, C., Ueno, Y., and Ishii, S. Binding of the c-myb proto-oncogene product to the simian virus 40 enhancer stimulates transcription. J. Biol. Chem., 265: 3479-3483, 1990.
10. Taylor, D., Badiani, P., and Weston, K. A dominant interfering Myb mutant causes apoptosis in T cells. Genes Dev., 10: 2732-2744, 1996.
11. Appleby, S. B., Ristimaki, A., Neilson, K., Narko, K., and Hla, T. Structure of the human cyclooxygenase-2 gene. Biochem. J., 302: 723-727, 1994.
12. Deng, Q. L., Ishii, S., and Sarai, A. Binding site analysis of c-Myb: screening of potential binding sites by using the mutation matrix derived from systematic binding affinity measurements. Nucleic Acids Res., 24: 766-774, 1996.
13. Wang, L. H., Hajibeigi, A., Xu, X. M., Loose-Mitchell, D., and Wu, K. K. Characterization of the promoter of human prostaglandin H synthase-1 gene. Biochem. Biophys. Res, Commun., 190: 406-411, 1993.
14. Sirois, J., Levy, L. O., Simmons, D. L., and Richards, J. S. Characterization and hormonal regulation of the promoter of the rat prostaglandin endoperoxide synlhase 2 gene in granulosa cells. Identification of functional and protein-binding regions. J. Biol. Chem., 268: 12199-12206, 1993.
15. Weston, K. Myb proteins in life, death and differentiation. Curr. Opin. Genet. Dev., 8: 76-81, 1998.
16. Kim, Y., and Fischer, S. M. Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues. J. Biol Chem., 273: 27686-27694, 1998.
17. Alexander, R. J., Buxbaum, J. N., and Raicht, R. F. Oncogene alterations in rat colon tumors induced by N-methyl-N- nitrosourea. Am. J. Med. Sci., 303: 16-24, 1992.
18. Zorbas, M., Sicurella, C., Bertoncello, I., Venter, D., Ellis, S., Mucenski, M. L.. and Ramsay, R. G. c-Myb is critical for murine colon development. Oncogene, 18: 5821-5830, 1999.
19. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.
20. Del Bufalo, D., Cucco, C., Leonetti, C., Citro, G., D'Agnano, I., Benassi, M., Geiser, T., Zon, G., Calabretta, B., and Zupi, G. Effect of cisplatin and c-myb anlisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo. Br. J. Cancer, 74: 387-393, 1996.